EORTC 62113-55115

Trial Description: 
A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Uterine Sarcoma
Trial Status: 
Recruiting
Contact person: